LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases.
For the mitochondrial disease community, the centrepiece of this ambitious initiative is the £7.5 million LifeArc Centre for Rare Mitochondrial Diseases, which will serve as a national platform in the UK to connect specialists, patients, knowledge and infrastructure in order to speed up getting new treatments to clinical trial.
The LifeArc Centre for Rare Mitochondrial Diseases is a national partnership with the Lily Foundation and Muscular Dystrophy UK. It will be led by Professor Patrick Chinnery, Professor of Neurology at the University of Cambridge and Honorary Consultant Neurologist at Cambridge University Hospitals NHS Trust, and key partners at University College London, Newcastle University and three other centres (Oxford, Birmingham and Manchester).
For further information on this exciting launch, please see LifeArc, The Lily Foundation and Muscular Dystrophy UK (MDUK) webpages for further information.